Concepts (58)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hemarthrosis | 4 | 2018 | 15 | 1.150 |
Why?
|
| Hemophilia A | 5 | 2018 | 41 | 0.750 |
Why?
|
| Factor VIII | 4 | 2018 | 26 | 0.710 |
Why?
|
| Synovitis | 3 | 2008 | 22 | 0.410 |
Why?
|
| Joint Diseases | 3 | 2008 | 110 | 0.320 |
Why?
|
| Disease Models, Animal | 5 | 2018 | 724 | 0.280 |
Why?
|
| Mice, Knockout | 4 | 2018 | 303 | 0.270 |
Why?
|
| Mice | 6 | 2018 | 1607 | 0.260 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2004 | 31 | 0.250 |
Why?
|
| Nuclear Proteins | 1 | 2004 | 88 | 0.240 |
Why?
|
| Animals | 6 | 2018 | 4552 | 0.200 |
Why?
|
| ADAM17 Protein | 1 | 2018 | 3 | 0.170 |
Why?
|
| Carrier Proteins | 1 | 2018 | 97 | 0.160 |
Why?
|
| Bone Resorption | 1 | 2018 | 104 | 0.160 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2018 | 215 | 0.150 |
Why?
|
| Blood Coagulation Tests | 1 | 2016 | 12 | 0.150 |
Why?
|
| Coagulants | 1 | 2016 | 9 | 0.140 |
Why?
|
| Joints | 1 | 2016 | 97 | 0.140 |
Why?
|
| Signal Transduction | 1 | 2018 | 482 | 0.140 |
Why?
|
| Severity of Illness Index | 1 | 2016 | 1113 | 0.100 |
Why?
|
| Factor IX | 1 | 2008 | 5 | 0.080 |
Why?
|
| Hemophilia B | 1 | 2008 | 10 | 0.080 |
Why?
|
| Synovial Membrane | 2 | 2008 | 81 | 0.080 |
Why?
|
| X-Ray Microtomography | 1 | 2008 | 72 | 0.080 |
Why?
|
| Genetic Therapy | 1 | 2008 | 89 | 0.080 |
Why?
|
| Recombinant Proteins | 1 | 2008 | 251 | 0.080 |
Why?
|
| Proteoglycans | 1 | 2008 | 337 | 0.070 |
Why?
|
| Platelet Adhesiveness | 1 | 2006 | 1 | 0.070 |
Why?
|
| Gangliosides | 1 | 2006 | 6 | 0.070 |
Why?
|
| Neuroblastoma | 1 | 2006 | 19 | 0.070 |
Why?
|
| Blood Platelets | 1 | 2006 | 49 | 0.070 |
Why?
|
| Genes, myc | 1 | 2004 | 6 | 0.060 |
Why?
|
| Oncogenes | 1 | 2004 | 13 | 0.060 |
Why?
|
| DNA, Complementary | 1 | 2004 | 28 | 0.060 |
Why?
|
| Iron | 1 | 2004 | 22 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2004 | 58 | 0.060 |
Why?
|
| Cell Division | 1 | 2004 | 113 | 0.060 |
Why?
|
| RNA | 1 | 2004 | 39 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2004 | 29 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 145 | 0.060 |
Why?
|
| Fibroblasts | 1 | 2004 | 95 | 0.060 |
Why?
|
| Cartilage, Articular | 1 | 2008 | 524 | 0.060 |
Why?
|
| Humans | 4 | 2016 | 29337 | 0.050 |
Why?
|
| Time Factors | 1 | 2004 | 1616 | 0.040 |
Why?
|
| Biological Availability | 1 | 2008 | 26 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 2008 | 56 | 0.020 |
Why?
|
| Dependovirus | 1 | 2008 | 37 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2008 | 60 | 0.020 |
Why?
|
| Injections, Intra-Articular | 1 | 2008 | 88 | 0.020 |
Why?
|
| Hemorrhage | 1 | 2008 | 75 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2008 | 432 | 0.020 |
Why?
|
| Blood Flow Velocity | 1 | 2006 | 19 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2006 | 43 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2006 | 101 | 0.020 |
Why?
|
| Collagen | 1 | 2006 | 102 | 0.020 |
Why?
|
| Stress, Mechanical | 1 | 2006 | 166 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2006 | 264 | 0.020 |
Why?
|
| Female | 1 | 2018 | 16197 | 0.010 |
Why?
|